Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates thr…
Industry Peers
Diagnostics & Research| Headline | Source | Time |
|---|---|---|
Older | ||
IPG Photonics (IPGP) Is Up 14.4% After Q2 Beat And Lumibird Deal Plan Has The Bull Case Changed? In the past week, IPG Photonics Corporation reported second-quarter 2026 results showing sales rising to US$278.58 million from US$250.72 million a year earlier, while net income eased to US$5.24 million from US$6.61 million and basic earnings per share from continuing operations moved to US$0.12 from US$0.16. Alongside this, IPG Photonics highlighted ongoing 11% year-over-year revenue growth driven by industrial and emerging laser applications, beat profit expectations, and announced a... | ||
LLe Monde du Droit | ||
CCFNEWS | ||
IPG Photonics Targets Medical Laser Growth With €300M Lumibird Medical Deal IPG Photonics (NASDAQ:IPGP) said it has signed a binding offer with Lumibird SA to acquire Lumibird Medical, a medical laser systems business focused primarily on ophthalmology, in a transaction the company said would expand its exposure to higher-margin medical markets. On a conference call discus | ||
Exploring Europe's Undiscovered Gems With Strong Potential May 2026 As European markets navigate a landscape of easing geopolitical tensions and robust corporate earnings, the pan-European STOXX Europe 600 Index has shown modest gains, reflecting a cautiously optimistic sentiment despite external pressures such as potential U.S. tariffs. Against this backdrop, identifying stocks with strong fundamentals and resilience to economic fluctuations can be particularly rewarding for investors seeking opportunities in Europe's diverse market landscape. | ||
3 European Stocks Estimated To Be Up To 36.2% Below Intrinsic Value Amidst the recent downturn in European markets, where the pan-European STOXX Europe 600 Index and major stock indexes like Germany’s DAX and France’s CAC 40 have all experienced declines, investors are increasingly on the lookout for opportunities that might be overlooked. In such a climate, identifying stocks that are trading below their intrinsic value can offer potential avenues for growth, as these investments may provide a margin of safety against market volatility. | ||
3 European Stocks Estimated To Be Up To 45.3% Below Intrinsic Value As European markets navigate mixed performances amid global growth concerns and a stronger euro, investors are increasingly focused on identifying stocks that may be undervalued relative to their intrinsic value. In such an environment, assessing stocks with strong fundamentals and potential for growth can be particularly appealing for those looking to capitalize on market inefficiencies. | ||